001022194 001__ 1022194
001022194 005__ 20240226075433.0
001022194 037__ $$aFZJ-2024-01315
001022194 1001_ $$0P:(DE-Juel1)177611$$aDrzezga, Alexander$$b0$$ufzj
001022194 1112_ $$cBrüssel$$d2023-11-12 - 2023-11-12$$wBelgium
001022194 245__ $$aMember-state field reports and good-practice examples, SAMIRA Study on the Implementation of the Euratom and EU Legal Bases with Respect to the Therapeutic Uses of Radiopharmaceuticals (SIMPLERAD) by The European Institute for Biomedical Imaging Research (EIBIR)
001022194 260__ $$c2023
001022194 3367_ $$033$$2EndNote$$aConference Paper
001022194 3367_ $$2DataCite$$aOther
001022194 3367_ $$2BibTeX$$aINPROCEEDINGS
001022194 3367_ $$2ORCID$$aLECTURE_SPEECH
001022194 3367_ $$0PUB:(DE-HGF)31$$2PUB:(DE-HGF)$$aTalk (non-conference)$$btalk$$mtalk$$s1706710723_29030$$xOther
001022194 3367_ $$2DINI$$aOther
001022194 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001022194 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x1
001022194 909CO $$ooai:juser.fz-juelich.de:1022194$$pVDB
001022194 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177611$$aForschungszentrum Jülich$$b0$$kFZJ
001022194 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001022194 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x1
001022194 9141_ $$y2023
001022194 920__ $$lyes
001022194 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
001022194 980__ $$atalk
001022194 980__ $$aVDB
001022194 980__ $$aI:(DE-Juel1)INM-2-20090406
001022194 980__ $$aUNRESTRICTED